Incyte Corporation
INCY
$119.52
-$3.47-2.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 26.93% | 21.48% | 21.22% | 18.09% | 18.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.93% | 21.48% | 21.22% | 18.09% | 18.87% |
| Cost of Revenue | 11.75% | -13.84% | -16.99% | -21.39% | -12.76% |
| Gross Profit | 42.32% | 91.90% | 105.46% | 111.96% | 88.07% |
| SG&A Expenses | 6.54% | 8.72% | 10.78% | 12.03% | 14.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.87% | -7.06% | -8.71% | -11.61% | -4.57% |
| Operating Income | 90.80% | 593.42% | 1,494.43% | 5,976.69% | 1,385.89% |
| Income Before Tax | 55.84% | 463.74% | 425.68% | 479.94% | 259.53% |
| Income Tax Expenses | -9.35% | 16.60% | 33.02% | 65.57% | 54.26% |
| Earnings from Continuing Operations | 85.15% | 6,631.44% | 3,844.96% | 3,559.21% | 795.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 85.15% | 6,631.44% | 3,844.96% | 3,559.21% | 795.08% |
| EBIT | 90.80% | 593.42% | 1,494.43% | 5,976.69% | 1,385.89% |
| EBITDA | 83.76% | 417.38% | 728.90% | 1,079.01% | 578.91% |
| EPS Basic | 80.67% | 1,854.15% | 2,012.89% | 3,563.21% | 1,088.25% |
| Normalized Basic EPS | 80.71% | 312.73% | 487.43% | 655.89% | 416.93% |
| EPS Diluted | 78.54% | 2,126.44% | 2,291.76% | 4,144.74% | 1,119.66% |
| Normalized Diluted EPS | 78.27% | 316.42% | 496.76% | 664.94% | 419.07% |
| Average Basic Shares Outstanding | 2.50% | -1.41% | -5.75% | -9.65% | -13.19% |
| Average Diluted Shares Outstanding | 3.93% | 0.26% | -4.24% | -8.25% | -11.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |